ABSTRACT
Species of the Vibrio genus occupy diverse aquatic environments ranging from brackish water to warm equatorial seas to salty coastal regions. More than 80 species of Vibrio have been identified, many of them as pathogens of marine organisms, including fish, shellfish, and corals, causing disease and wreaking havoc on aquacultures and coral reefs. Moreover, many Vibrio species associate with and thrive on chitinous organisms abundant in the ocean. Among the many diverse Vibrio species, the most well-known and studied is Vibrio cholerae, discovered in the 19th century to cause cholera in humans when ingested. The V. cholerae field blossomed in the late 20th century, with studies broadly examining V. cholerae evolution as a human pathogen, natural competence, biofilm formation, and virulence mechanisms, including toxin biology and virulence gene regulation. This review discusses some of the historic discoveries of V. cholerae biology and ecology as one of the fundamental model systems of bacterial genetics and pathogenesis.
KEYWORDS: Vibrio, Vibrio cholerae, virulence factors, pathogenesis, genetic competence, quorum sensing, toxins
INTRODUCTION
Those of us who study Vibrio species in our laboratories know that most people have only heard of one Vibrio – the causative agent of the disease cholera. V. cholerae is one of the more infamous human pathogens of modern times, yet it has likely plagued humankind for thousands of years (1, 2) (Fig. 1). Cholera is contracted when people consume water contaminated with V. cholerae bacteria. Once these cells survive passage through the stomach’s acidic environment, they colonize the small intestine, delivering a toxin to the host epithelium that drives the copious release of ions and water into the gut lumen. The resulting profuse secretory diarrhea results in severe fluid volume depletion, which may lead to circulatory collapse and death. Standard and effective treatment, if available, is intravenous or oral hydration. Although seemingly a simple treatment, many outbreaks of cholera are linked to poor sanitation conditions or catastrophic events, thus precluding the availability of treatment in many affected regions. The World Health Organization (WHO) describes the current situation worldwide as an “upsurge of the 7th pandemic,” with numerous ongoing outbreaks reported and efforts being coordinated to perform surveillance, vaccination, prevention, case management, and increased assessment and response actions (3).
Fig 1.
Timeline of major discoveries in Vibrio cholerae and cholera.
Although several regions of the world struggle with the ongoing 7th pandemic of cholera that began in 1961, many bacteriologists have latched onto V. cholerae as an organism for studying mechanisms of bacterial behaviors, genetics, ecology, evolution, and more. Here, we describe some of the discoveries in the V. cholerae field that led to this comma-shaped bacterium becoming a fundamental model organism for bacterial research.
THE BEGINNING OF THE SCIENTIFIC STUDY OF V. CHOLERAE
Likely, cholera originated thousands of years ago, given that the Sanskrit word “visuchika,” which accurately describes cholera symptoms, was used as early as 400 B.C.E. (1, 2). In modern times, the first recorded pandemic began in 1817 and ended around 1824. There have since been six more pandemics, with the ongoing 7th pandemic showing no signs of dwindling. The second half of the 19th century saw momentous discoveries in the cholera field. In 1853, during the 3rd pandemic, Filippo Pacini used his microscopy expertise to view and describe for the first time the presence of comma-shaped bacilli, which he named Vibrio cholera, in samples from people who had died of cholera. In 1884, Robert Koch’s bacterial cultivation techniques enabled him to successfully grow V. cholerae on solid media (first on sliced potatoes, later on agar), and he detailed its phenotypical characteristics (4). In 1855, John Snow diligently described and documented the 1854 London cholera outbreak and correctly proposed the spread of the disease through contaminated water (5). This discovery was revolutionary because it was dogma at the time that cholera was caused by bad air.
Decades later, in 1916, the initial “fingerprinting” of V. cholerae strains began, in which the characteristics of each strain were used to classify subtypes (6). Hemolysis or hemagglutination activity and phage-typing were the earliest technologies to be utilized until the onset of the molecular and genomic era enabled more accurate approaches: PCR, chromosome mapping, and eventually whole genome sequencing (7).
Here, we briefly review some seminal works from modern times on V. cholerae to highlight its broad impact as a model organism.
TOXIN BIOLOGY
Among the many discoveries of novel molecular biology and pathogenesis mechanisms in V. cholerae, one of the first and most famous is identifying cholera toxin (CT). Groundbreaking experiments published by Sambhu Nath De and colleagues in the 1950s using the rabbit ligated loop model system revealed that the toxic effects of V. cholerae target the intestinal mucosa, causing fluid secretion (8–12). Their seminal paper in 1959, showing that the effector of these phenotypes could be derived from V. cholerae culture supernatants, led to many more studies that unveiled the existence of CT (8). Later, CT was purified and characterized in vitro and assayed in vivo, showing that it comprises two peptide subunits, A (toxic-active) and B (binding), that interact with the GM1 ganglioside receptor on host intestinal cell membranes (13–19). Decades of molecular, genetic, biochemical, structural, immunological, and cell biological studies of CT and its effects on the host provided models for enterotoxins in other organisms, paradigm shifts in vaccine development, and cholera disease treatment (20).
IDENTIFICATION OF VIRULENCE GENES AND THEIR REGULATION
Notably, the vast majority of the >200 V. cholerae serogroups do not produce CT and thus do not cause cholera. One serogroup, O1 (divided into O1 El Tor and classical biotypes) is believed to be responsible for all seven recorded pandemics (21). Some, but not all strains of the O1 serogroup, cause disease because they carry specific virulence genes, including the CTXΦ prophage, which encodes the CT-coding genes ctxA and ctxB. The discoveries of the CTXΦ and Vibrio pathogenicity islands (VPIs) encoding other key virulence factors marked another paradigm shift in understanding cholera biology and pathogenesis Box 1 (22–34). Multiple signal transduction circuits were uncovered that enable V. cholerae to sense and respond to external stimuli, such as bile, salt, pH, and temperature (35). These pathways drive control of virulence genes via ToxR, which, together with ToxS, directly or indirectly regulate major virulence genes: ctxAB and the genes encoding the major colonization factor and receptor for the CTXΦ phage, the toxin co-regulated pilus (TCP), among others (22–24, 26, 32, 33).
Box 1. Unraveling the mysteries of cholera: the legacy of Ron Taylor.
For three decades (1986–2016), the late Ronald K. Taylor led an incredibly productive genetics-based investigation into the heart of cholera — How V. cholerae turns on virulence genes upon entry into the human GI tract and how it colonizes the small intestine. During this period, he trained numerous scientists in the classroom and laboratory, as well as in Cold Spring Harbor’s Advanced Bacterial Genetics course. He also contributed important genetic tools and methodologies to the field. He first learned genetic sleuthing during his graduate training with Thomas Silhavy at the University of Maryland Baltimore. Ron, with his postdoctoral mentor, John Mekalanos, at Harvard Medical School, then turned his attention to unveiling the mysteries of V. cholerae. Ron’s discoveries are too many and varied to list all, but some highlights vis-à-vis V. cholerae virulence include:
| 1987–1989 | Toxin-coregulated pilus (TCP) is the major virulence factor (36). TnphoA-mediated discovery of TCP pilin and other exported virulence factors (22, 37). Defined the ToxR binding site within the cholera toxin operon promoter (23, 38). |
| 1990 | Anti-TCP antibodies protect against infection (39). |
| 1992 | TcpG catalyzes disulfide bond formation in multiple virulence proteins (40). |
| 1995–2000 | Identified key residues on TCP for microcolony formation, adherence, and antigenicity (41–43). |
| 1997–2000 | cAMP-CRP and H-NS repress virulence genes outside the host (44, 45). Identification of environmental signals controlling virulence gene regulation (35). |
| 2003–2011 | TcpF is a TCP-dependent secreted factor that is essential for colonization (46–49). GbpA binds chitin in the environment and receptors in the small intestine (50). |
CHITIN UTILIZATION, NATURAL COMPETENCE, AND ECOLOGY
Chitin is the most abundant polymer in the ocean (51). Many organisms, including V. cholerae, have evolved to utilize chitin as a carbon and nitrogen source. V. cholerae is typically associated with chitinous surfaces in its aquatic lifestyle and reservoir. The influence of chitin on V. cholerae catabolism, ecology, and genetic exchange became apparent in the 2000s when it was discovered that growth on chitin induced the expression of a suite of genes for chitin utilization and natural competence (52). This discovery has been further explored, revealing a variety of molecular mechanisms, including chitin sensing, chitin-binding pilus, chitin uptake, regulation of downstream genes, DNA-binding pilus, DNA uptake, and recombination, and the impact of chitin on other systems, such as type VI secretion (53). The chitin-regulated processes extend beyond catabolism to genetic transfer and evolution, chemotaxis, biofilm formation, community structure, symbiotic and pathogenic relationships, nutrient cycling, and more (51). Studies of V. cholerae and the role of chitin on its biophysiology are broadly important to our understanding of the complex evolutionary history of water-borne, facultative pathogens.
QUORUM SENSING
Much of the early work uncovering the bacterial cell–cell communication process called quorum sensing was performed in two Vibrio species: Vibrio fischeri and Vibrio harveyi (54–67). Of note, the strain V. harveyi BB120 (with which most studies referred to herein were performed) was later re-classified as Vibrio campbellii (68). This work was sparked by the ability of these two organisms to produce bioluminescence regulated by quorum sensing, thus providing an easily accessible phenotype to study the genetics and chemistry of the quorum-sensing signaling pathways. As Vibrio autoinducer signals and receptors were discovered in V. campbellii and V. fischeri, new experiments showed that other Vibrio species, including V. cholerae, could signal to V. campbellii (69). Soon afterward, homologs of quorum-sensing system components as key virulence regulators were discovered in V. cholerae (70). Indeed, subsequent studies revealed that quorum sensing regulates the genes that control biofilm formation and virulence, including biofilm activators VpsR and VpsT, protease HapA, transcription activators AphA/AphB, and virulence activators TcpPH and thus ToxT (reviewed further in (70–77). Identifying the V. cholerae-specific autoinducer CAI-1 structure paved the way for many studies of quorum-sensing signals, receptor specificity, and virulence gene regulation in V. cholerae (78).
CONTACT-DEPENDENT KILLING
The discovery of type VI secretion systems (T6SSs) in V. cholerae marks another paradigm shift in our understanding of bacterial interactions. In 2006, it was revealed that V. cholerae could fend off predation by the protist Dictyostelium, and the T6SS encoding vas genes responsible were identified (79). Using a combination of approaches, the field determined the structure of T6SS “nanomachine,” observed its live assembly, firing, and disassembly, and the effects of delivery of effector proteins into target cells (80–85). Later studies revealed the regulatory mechanisms controlling T6SS, the broad conservation of T6SS among Gram-negative bacteria, and the impact of T6SS on horizontal gene transfer, leading to evolution and divergence in T6SS repertoires (86–92). The now-clear role of T6SS in competition between bacterial species within mixed communities was found to drive competition in numerous niches beyond those occupied by V. cholerae. As examples, these include (1) symbiotic interactions, such as V. fischeri interstrain competitions that drive strain colonization in the squid Euprymna scolopes (93), (2) pathogenic interactions, such as the competition between Agrobacterium tumefaciens with Pseudomonas aeruginosa in plant infections (94), and (3) microbe–microbe interactions in environmental niches, such as the competitions between Bacteriodales in mammalian gut microbiota (95).
FUTURE OUTLOOK
The research on V. cholerae establishes this microbe as an exemplary model organism that continues to foster broad research across disciplines. The reasons that V. cholerae became a model microbe include its short generation time, simple requirements for growth, efficient genetic tools, and a long history of host biology coupled with clinical studies. V. cholerae research continues to expand and has become a model for additional fields, such as chromosome replication and organization, host signaling impacts on pathogenesis, phage/host arms race, and more. Although many microbes have served microbiology in notable capacities, it is arguable that V. cholerae has earned its place among the “greats.”
Contributor Information
Julia C. van Kessel, Email: jcvk@iu.edu.
Andrew Camilli, Email: andrew.camilli@tufts.edu.
George O'Toole, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
REFERENCES
- 1. Bishagratna KK. 1963. An english translation of the Sushruta Samhita. Bharat Mihir Press. [Google Scholar]
- 2. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. 2012. Cholera. Lancet 379:2466–2476. doi: 10.1016/S0140-6736(12)60436-X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Anonymous . n.d. World Health Organization. Available from: http://www.who.int/en/
- 4. Lippi D, Gotuzzo E, Caini S. 2016. Cholera. Microbiol Spectr 4. doi: 10.1128/microbiolspec.PoH-0012-2015 [DOI] [PubMed] [Google Scholar]
- 5. Tulchinsky TH. 2018. John Snow, Cholera, the Broad Street Pump; Waterborne Diseases Then and Now, p 77–99. In Case Stud in Public Health [Google Scholar]
- 6. Rahaman MH, Islam T, Colwell RR, Alam M. 2015. Molecular tools in understanding the evolution of Vibrio cholerae. Front Microbiol 6:1040. doi: 10.3389/fmicb.2015.01040 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Heidelberg JF, Eisen JA, Nelson WC, Clayton RA, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Umayam L, et al. 2000. DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae. Nat New Biol 406:477–483. doi: 10.1038/35020000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. DE SN. 1959. Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nat New Biol 183:1533–1534. doi: 10.1038/1831533a0 [DOI] [PubMed] [Google Scholar]
- 9. De SN, Chatterje DN. 1953. An experimental study of the mechanism of action of Vibrio cholerae on the intestinal mucous membrane. J Pathol Bacteriol 66:559–562. doi: 10.1002/path.1700660228 [DOI] [PubMed] [Google Scholar]
- 10. De SN, Ghose ML, Sen A. 1960. Activities of bacteria-free preparations from Vibrio cholerae. J Pathol Bacteriol 79:373–380. doi: 10.1002/path.1700790219 [DOI] [PubMed] [Google Scholar]
- 11. De SN, Bhattacharyya K, Roychandhury PK. 1954. The haemolytic activities of Vibrio cholerae and related vibrios. J Pathol Bacteriol 67:117–127. [PubMed] [Google Scholar]
- 12. De SN, Bhattacharyya K, Raychaudhury PK. 1952. In-vitro study of the actions of terramycin and chloromycetin against Vibrio cholerae; preliminary report. Calcutta Med J 49:360–361. [PubMed] [Google Scholar]
- 13. Finkelstein RA, Jehl JJ, Goth A. 1969. Pathogenesis of experimental cholera: choleragen-induced rat foot edema; a method of screening anticholera drugs. Proc Soc Exp Biol Med 132:835–840. doi: 10.3181/00379727-132-34318 [DOI] [PubMed] [Google Scholar]
- 14. Finkelstein RA, LoSpalluto JJ. 1969. Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid. J Exp Med 130:185–202. doi: 10.1084/jem.130.1.185 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Lönnroth I, Holmgren J. 1973. Subunit structure of cholera toxin. J Gen Microbiol 76:417–427. doi: 10.1099/00221287-76-2-417 [DOI] [PubMed] [Google Scholar]
- 16. Holmgren J, Lönnroth I, Svennerholm L. 1973. Fixation and inactivation of cholera toxin by GM1 ganglioside. Scand J Infect Dis 5:77–78. doi: 10.3109/inf.1973.5.issue-1.15 [DOI] [PubMed] [Google Scholar]
- 17. Holmgren J. 1981. Actions of cholera toxin and the prevention and treatment of cholera. Nature New Biol 292:413–417. doi: 10.1038/292413a0 [DOI] [PubMed] [Google Scholar]
- 18. Greenough WB, Stoll B, Holmgren J, Svennerholm L, Fredman P, Bardhan PK, Huq I. 1981. Toxin absorption in cholera. The Lancet 318:208. doi: 10.1016/S0140-6736(81)90396-2 [DOI] [PubMed] [Google Scholar]
- 19. Tayot JL, Holmgren J, Svennerholm L, Lindblad M, Tardy M. 1981. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside. Eur J Biochem 113:249–258. doi: 10.1111/j.1432-1033.1981.tb05060.x [DOI] [PubMed] [Google Scholar]
- 20. Sanchez J, Holmgren J. 2011. Cholera toxin - a foe & a friend. Indian J Med Res 133:153–163. [PMC free article] [PubMed] [Google Scholar]
- 21. Morris JG. 2011. Cholera--modern pandemic disease of ancient lineage. Emerg Infect Dis 17:2099–2104. doi: 10.3201/eid1711.111109 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ. 1987. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc Natl Acad Sci U S A 84:2833–2837. doi: 10.1073/pnas.84.9.2833 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Miller VL, Taylor RK, Mekalanos JJ. 1987. Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell 48:271–279. doi: 10.1016/0092-8674(87)90430-2 [DOI] [PubMed] [Google Scholar]
- 24. Karaolis DK, Johnson JA, Bailey CC, Boedeker EC, Kaper JB, Reeves PR. 1998. A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U S A 95:3134–3139. doi: 10.1073/pnas.95.6.3134 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Sporecke I, Castro D, Mekalanos JJ. 1984. Genetic mapping of Vibrio cholerae enterotoxin structural genes. J Bacteriol 157:253–261. doi: 10.1128/jb.157.1.253-261.1984 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Waldor MK, Mekalanos JJ. 1996. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 272:1910–1914. doi: 10.1126/science.272.5270.1910 [DOI] [PubMed] [Google Scholar]
- 27. Mekalanos JJ, Murphy JR. 1980. Regulation of cholera toxin production in Vibrio cholerae: genetic analysis of phenotypic instability in hypertoxinogenic mutants. J Bacteriol 141:570–576. doi: 10.1128/jb.141.2.570-576.1980 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Mekalanos JJ, Moseley SL, Murphy JR, Falkow S. 1982. Isolation of enterotoxin structural gene deletion mutations in Vibrio cholerae induced by two mutagenic vibriophages. Proc Natl Acad Sci USA 79:151–155. doi: 10.1073/pnas.79.1.151 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Pearson GD, Mekalanos JJ. 1982. Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12. Proc Natl Acad Sci USA 79:2976–2980. doi: 10.1073/pnas.79.9.2976 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Mekalanos JJ. 1983. Duplication and amplification of toxin genes in Vibrio cholerae. Cell 35:253–263. doi: 10.1016/0092-8674(83)90228-3 [DOI] [PubMed] [Google Scholar]
- 31. Pierce NF, Kaper JB, Mekalanos JJ, Cray WC. 1985. Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits. Infect Immun 50:813–816. doi: 10.1128/iai.50.3.813-816.1985 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, Levine MM. 1988. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 168:1487–1492. doi: 10.1084/jem.168.4.1487 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Peterson KM, Mekalanos JJ. 1988. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect Immun 56:2822–2829. doi: 10.1128/iai.56.11.2822-2829.1988 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Karaolis DKR, Somara S, Maneval DR, Johnson JA, Kaper JB. 1999. A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nat New Biol 399:375–379. doi: 10.1038/20715 [DOI] [PubMed] [Google Scholar]
- 35. Skorupski K, Taylor RK. 1997. Control of the ToxR virulence regulon in Vibrio cholerae by environmental stimuli. Mol Microbiol 25:1003–1009. doi: 10.1046/j.1365-2958.1997.5481909.x [DOI] [PubMed] [Google Scholar]
- 36. Taylor RK, Miller VL, Furlong DB, Mekalanos JJ. 1986. Identification of a pilus colonization factor that is coordinately regulated with cholera toxin. Ann Sclavo Collana Monogr 3:51–61. [PubMed] [Google Scholar]
- 37. Taylor RK, Manoil C, Mekalanos JJ. 1989. Broad-host-range vectors for delivery of TnphoA: use in genetic analysis of secreted virulence determinants of Vibrio cholerae. J Bacteriol 171:1870–1878. doi: 10.1128/jb.171.4.1870-1878.1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Pfau JD, Taylor RK. 1996. Genetic footprint on the ToxR-binding site in the promoter for cholera toxin. Mol Microbiol 20:213–222. doi: 10.1111/j.1365-2958.1996.tb02502.x [DOI] [PubMed] [Google Scholar]
- 39. Sun DX, Mekalanos JJ, Taylor RK. 1990. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J Infect Dis 161:1231–1236. doi: 10.1093/infdis/161.6.1231 [DOI] [PubMed] [Google Scholar]
- 40. Peek JA, Taylor RK. 1992. Characterization of a periplasmic thiol:disulfide interchange protein required for the functional maturation of secreted virulence factors of Vibrio cholerae. Proc Natl Acad Sci U S A 89:6210–6214. doi: 10.1073/pnas.89.13.6210 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Chiang SL, Taylor RK, Koomey M, Mekalanos JJ. 1995. Single amino acid substitutions in the N-terminus of Vibrio cholerae TcpA affect colonization, autoagglutination, and serum resistance. Mol Microbiol 17:1133–1142. doi: 10.1111/j.1365-2958.1995.mmi_17061133.x [DOI] [PubMed] [Google Scholar]
- 42. Sun D, Lafferty MJ, Peek JA, Taylor RK. 1997. Domains within the Vibrio cholerae toxin coregulated pilin subunit that mediate bacterial colonization. Gene 192:79–85. doi: 10.1016/s0378-1119(97)00007-3 [DOI] [PubMed] [Google Scholar]
- 43. Kirn TJ, Lafferty MJ, Sandoe CM, Taylor RK. 2000. Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae. Mol Microbiol 35:896–910. doi: 10.1046/j.1365-2958.2000.01764.x [DOI] [PubMed] [Google Scholar]
- 44. Skorupski K, Taylor RK. 1997. Cyclic AMP and its receptor protein negatively regulate the coordinate expression of cholera toxin and toxin-coregulated pilus in Vibrio cholerae. Proc Natl Acad Sci U S A 94:265–270. doi: 10.1073/pnas.94.1.265 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Nye MB, Pfau JD, Skorupski K, Taylor RK. 2000. Vibrio cholerae H-NS silences virulence gene expression at multiple steps in the ToxR regulatory cascade. J Bacteriol 182:4295–4303. doi: 10.1128/JB.182.15.4295-4303.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Krebs SJ, Kirn TJ, Taylor RK. 2009. Genetic mapping of secretion and functional determinants of the Vibrio cholerae TcpF colonization factor. J Bacteriol 191:3665–3676. doi: 10.1128/JB.01724-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Lim MS, Ng D, Zong Z, Arvai AS, Taylor RK, Tainer JA, Craig L. 2010. Vibrio cholerae El Tor TcpA crystal structure and mechanism for pilus-mediated microcolony formation. Mol Microbiol 77:755–770. doi: 10.1111/j.1365-2958.2010.07244.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Megli CJ, Yuen ASW, Kolappan S, Richardson MR, Dharmasena MN, Krebs SJ, Taylor RK, Craig L. 2011. Crystal structure of the Vibrio cholerae colonization factor TcpF and identification of a functional immunogenic site. J Mol Biol 409:146–158. doi: 10.1016/j.jmb.2011.03.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Kirn TJ, Bose N, Taylor RK. 2003. Secretion of a soluble colonization factor by the TCP type 4 pilus biogenesis pathway in Vibrio cholerae. Mol Microbiol 49:81–92. doi: 10.1046/j.1365-2958.2003.03546.x [DOI] [PubMed] [Google Scholar]
- 50. Kirn TJ, Jude BA, Taylor RK. 2005. A colonization factor links Vibrio cholerae environmental survival and human infection. Nat New Biol 438:863–866. doi: 10.1038/nature04249 [DOI] [PubMed] [Google Scholar]
- 51. Markov EY, Kulikalova ES, Urbanovich LY, Vishnyakov VS, Balakhonov SV. 2015. Chitin and products of its hydrolysis in Vibrio cholerae ecology. Biochem Mosc 80:1109–1116. doi: 10.1134/S0006297915090023 [DOI] [PubMed] [Google Scholar]
- 52. Meibom KL, Li XB, Nielsen AT, Wu CY, Roseman S, Schoolnik GK. 2004. The Vibrio cholerae chitin utilization program. Proc Natl Acad Sci U S A 101:2524–2529. doi: 10.1073/pnas.0308707101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Metzger LC, Blokesch M. 2016. Regulation of competence-mediated horizontal gene transfer in the natural habitat of Vibrio cholerae. Curr Opin Microbiol 30:1–7. doi: 10.1016/j.mib.2015.10.007 [DOI] [PubMed] [Google Scholar]
- 54. Engebrecht J, Nealson K, Silverman M. 1983. Bacterial bioluminescence: isolation and genetic analysis of functions from Vibrio fischeri. Cell 32:773–781. doi: 10.1016/0092-8674(83)90063-6 [DOI] [PubMed] [Google Scholar]
- 55. Shadel GS, Devine JH, Baldwin TO. 1990. Control of the lux regulon of Vibrio fischeri. J Biolumin Chemilumin 5:99–106. doi: 10.1002/bio.1170050205 [DOI] [PubMed] [Google Scholar]
- 56. Choi SH, Greenberg EP. 1991. The C-terminal region of the Vibrio fischeri LuxR protein contains an inducer-independent lux gene activating domain. Proc Natl Acad Sci U S A 88:11115–11119. doi: 10.1073/pnas.88.24.11115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Choi SH, Greenberg EP. 1992. Genetic dissection of DNA binding and luminescence gene activation by the Vibrio fischeri LuxR protein. J Bacteriol 174:4064–4069. doi: 10.1128/jb.174.12.4064-4069.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Schaefer AL, Hanzelka BL, Eberhard A, Greenberg EP. 1996. Quorum sensing in Vibrio fischeri: probing autoinducer-LuxR interactions with autoinducer analogs. J Bacteriol 178:2897–2901. doi: 10.1128/jb.178.10.2897-2901.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Greenberg EP, Hastings JW, Ulitzur S. 1979. Induction of luciferase Synthesis in Beneckea harveyi by other marine bacteria. Arch Microbiol 120:87–91. doi: 10.1007/BF00409093 [DOI] [Google Scholar]
- 60. Belas R, Mileham A, Cohn D, Hilman M, Simon M, Silverman M. 1982. Bacterial bioluminescence: isolation and expression of the luciferase genes from Vibrio harveyi. Science 218:791–793. doi: 10.1126/science.10636771 [DOI] [PubMed] [Google Scholar]
- 61. Cao JG, Meighen EA. 1989. Purification and structural identification of an autoinducer for the luminescence system of Vibrio harveyi. J Biol Chem 264:21670–21676. [PubMed] [Google Scholar]
- 62. Martin M, Showalter R, Silverman M. 1989. Identification of a locus controlling expression of luminescence genes in Vibrio harveyi. J Bacteriol 171:2406–2414. doi: 10.1128/jb.171.5.2406-2414.1989 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Showalter RE, Martin MO, Silverman MR. 1990. Cloning and nucleotide sequence of luxR, a regulatory gene controlling bioluminescence in Vibrio harveyi. J Bacteriol 172:2946–2954. doi: 10.1128/jb.172.6.2946-2954.1990 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Swartzman E, Silverman M, Meighen EA. 1992. The luxR gene product of Vibrio harveyi is a transcriptional activator of the lux promoter. J Bacteriol 174:7490–7493. doi: 10.1128/jb.174.22.7490-7493.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Bassler BL, Wright M, Showalter RE, Silverman MR. 1993. Intercellular signalling in Vibrio harveyi: sequence and function of genes regulating expression of luminescence. Mol Microbiol 9:773–786. doi: 10.1111/j.1365-2958.1993.tb01737.x [DOI] [PubMed] [Google Scholar]
- 66. Bassler BL, Wright M, Silverman MR. 1994. Multiple signalling systems controlling expression of luminescence in Vibrio harveyi: sequence and function of genes encoding a second sensory pathway. Mol Microbiol 13:273–286. doi: 10.1111/j.1365-2958.1994.tb00422.x [DOI] [PubMed] [Google Scholar]
- 67. Bassler BL, Wright M, Silverman MR. 1994. Sequence and function of LuxO, a negative regulator of luminescence in Vibrio harveyi. Mol Microbiol 12:403–412. doi: 10.1111/j.1365-2958.1994.tb01029.x [DOI] [PubMed] [Google Scholar]
- 68. Lin B, Wang Z, Malanoski AP, O’Grady EA, Wimpee CF, Vuddhakul V, Alves N, Thompson FL, Gomez-Gil B, Vora GJ. 2010. Comparative genomic analyses identify the Vibrio harveyi genome sequenced strains BAA-1116 and HY01 as Vibrio campbellii. Environ Microbiol Rep 2:81–89. doi: 10.1111/j.1758-2229.2009.00100.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Bassler BL, Greenberg EP, Stevens AM. 1997. Cross-species induction of luminescence in the quorum-sensing bacterium Vibrio harveyi. J Bacteriol 179:4043–4045. doi: 10.1128/jb.179.12.4043-4045.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. 2002. Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A 99:3129–3134. doi: 10.1073/pnas.052694299 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Rutherford ST, Bassler BL. 2012. Bacterial quorum sensing: its role in virulence and possibilities for its control. Cold Spring Harb Perspect Med 2:a012427. doi: 10.1101/cshperspect.a012427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72. Kovacikova G, Skorupski K. 1999. A Vibrio cholerae LysR homolog, AphB, cooperates with AphA at the tcpPH promoter to activate expression of the ToxR virulence cascade. J Bacteriol 181:4250–4256. doi: 10.1128/JB.181.14.4250-4256.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Skorupski K, Taylor RK. 1999. A new level in the Vibrio cholerae ToxR virulence cascade: AphA is required for transcriptional activation of the tcpPH operon. Mol Microbiol 31:763–771. doi: 10.1046/j.1365-2958.1999.01215.x [DOI] [PubMed] [Google Scholar]
- 74. Kovacikova G, Skorupski K. 2002. Regulation of virulence gene expression in Vibrio cholerae by quorum sensing: HapR functions at the aphA promoter. Mol Microbiol 46:1135–1147. doi: 10.1046/j.1365-2958.2002.03229.x [DOI] [PubMed] [Google Scholar]
- 75. Withey JH, DiRita VJ. 2006. The toxbox: specific DNA sequence requirements for activation of Vibrio cholerae virulence genes by ToxT. Mol Microbiol 59:1779–1789. doi: 10.1111/j.1365-2958.2006.05053.x [DOI] [PubMed] [Google Scholar]
- 76. Matson JS, Withey JH, DiRita VJ. 2007. Regulatory networks controlling Vibrio cholerae virulence gene expression. Infect Immun 75:5542–5549. doi: 10.1128/IAI.01094-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77. Hammer BK, Bassler BL. 2003. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol 50:101–104. doi: 10.1046/j.1365-2958.2003.03688.x [DOI] [PubMed] [Google Scholar]
- 78. Higgins DA, Pomianek ME, Kraml CM, Taylor RK, Semmelhack MF, Bassler BL. 2007. The major Vibrio cholerae autoinducer and its role in virulence factor production. Nat New Biol 450:883–886. doi: 10.1038/nature06284 [DOI] [PubMed] [Google Scholar]
- 79. Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, Heidelberg JF, Mekalanos JJ. 2006. Identification of a conserved bacterial protein secretion system in Vibrio cholerae using the Dictyostelium host model system. Proc Natl Acad Sci U S A 103:1528–1533. doi: 10.1073/pnas.0510322103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. 2007. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A 104:15508–15513. doi: 10.1073/pnas.0706532104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ. 2012. Type VI secretion requires a dynamic contractile phage tail-like structure. Nat New Biol 483:182–186. doi: 10.1038/nature10846 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82. Ma AT, McAuley S, Pukatzki S, Mekalanos JJ. 2009. Translocation of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by host cells. Cell Host Microbe 5:234–243. doi: 10.1016/j.chom.2009.02.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Ma AT, Mekalanos JJ. 2010. In vivo actin cross-linking induced byVibrio choleraetype VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci USA 107:4365–4370. doi: 10.1073/pnas.0915156107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84. Leiman PG, Basler M, Ramagopal UA, Bonanno JB, Sauder JM, Pukatzki S, Burley SK, Almo SC, Mekalanos JJ. 2009. Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin. Proc Natl Acad Sci U S A 106:4154–4159. doi: 10.1073/pnas.0813360106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85. Unterweger D, Miyata ST, Bachmann V, Brooks TM, Mullins T, Kostiuk B, Provenzano D, Pukatzki S. 2014. The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition. Nat Commun 5:3549. doi: 10.1038/ncomms4549 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86. Zheng J, Shin OS, Cameron DE, Mekalanos JJ. 2010. Quorum sensing and a global regulator TsrA control expression of type VI secretion and virulence in Vibrio cholerae. Proc Natl Acad Sci U S A 107:21128–21133. doi: 10.1073/pnas.1014998107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87. Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ. 2013. Identification of T6SS-dependent effector and immunity proteins by Tn-seq in Vibrio cholerae. Proc Natl Acad Sci U S A 110:2623–2628. doi: 10.1073/pnas.1222783110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88. Shao Y, Bassler BL. 2014. Quorum regulatory small RNAs repress type VI secretion in Vibrio cholerae. Mol Microbiol 92:921–930. doi: 10.1111/mmi.12599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89. Blokesch M. 2015. Competence-induced type VI secretion might foster intestinal colonization by Vibrio cholerae: intestinal interbacterial killing by competence-induced V. cholerae. Bioessays 37:1163–1168. doi: 10.1002/bies.201500101 [DOI] [PubMed] [Google Scholar]
- 90. Borgeaud S, Metzger LC, Scrignari T, Blokesch M. 2015. The type VI secretion system of Vibrio cholerae fosters horizontal gene transfer. Science 347:63–67. doi: 10.1126/science.1260064 [DOI] [PubMed] [Google Scholar]
- 91. Salomon D, Klimko JA, Trudgian DC, Kinch LN, Grishin NV, Mirzaei H, Orth K. 2015. Type VI secretion system toxins horizontally shared between marine bacteria. PLoS Pathog 11:e1005128. doi: 10.1371/journal.ppat.1005128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92. Metzger LC, Stutzmann S, Scrignari T, Van der Henst C, Matthey N, Blokesch M. 2016. Independent regulation of type VI secretion in Vibrio cholerae by TfoX and TfoY. Cell Rep 15:951–958. doi: 10.1016/j.celrep.2016.03.092 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93. Sun Y, LaSota ED, Cecere AG, LaPenna KB, Larios-Valencia J, Wollenberg MS, Miyashiro T. 2016. Intraspecific competition impacts Vibrio fischeri strain diversity during initial colonization of the squid light organ. Appl Environ Microbiol 82:3082–3091. doi: 10.1128/AEM.04143-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94. Ma LS, Hachani A, Lin JS, Filloux A, Lai EM. 2014. Agrobacterium tumefaciens deploys a superfamily of type VI secretion DNase effectors as weapons for interbacterial competition in planta. Cell Host Microbe 16:94–104. doi: 10.1016/j.chom.2014.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95. Chatzidaki-Livanis M, Geva-Zatorsky N, Comstock LE. 2016. Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species. Proc Natl Acad Sci U S A 113:3627–3632. doi: 10.1073/pnas.1522510113 [DOI] [PMC free article] [PubMed] [Google Scholar]

